NCT01051661 - Safety and Efficacy of H1N1 Vaccines in Children Aged 6 Months to Less Than 10 Years of Age | Biotech Hunter

Enrollment

6,154

Participants

Timeline

Start Date

February 12, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

September 9, 2011

Conditions

Influenza

Interventions

BIOLOGICAL

GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations)

Intramuscular injection, one or two doses

BIOLOGICAL

GSK Biologicals' investigational vaccine GSK2340273A (alternative formulations)

Intramuscular injection, two doses

BIOLOGICAL

Placebo

Intramuscular injection, one dose

Trial Locations (17)

1008

GSK Investigational Site, Sampaloc, Manila

1781

GSK Investigational Site, City of Muntinlupa

3053

GSK Investigational Site, Carlton

3400

GSK Investigational Site, Durango

4021

GSK Investigational Site, Kippa-Ring

4114

GSK Investigational Site, Dasmariñas, Cavite

10400

GSK Investigational Site, Bangkok

40002

GSK Investigational Site, Khon Kaen

768826

GSK Investigational Site, Singapore

88025 300

GSK Investigational Site, Florianópolis

04038 001

GSK Investigational Site, São Paulo

Unknown

GSK Investigational Site, São Paulo

GSK Investigational Site, Santiago de Cali

GSK Investigational Site, San José

GSK Investigational Site, Cuernavaca

GSK Investigational Site, Monterrey

04530

GSK Investigational Site, Mexico City